HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James C Stolzenbach Selected Research

fenofibric acid

6/2014Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
8/2013A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
2/2011Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
2/2011Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
12/2010Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.
10/2010Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia.
10/2010Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
1/2010Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
1/2010Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
5/2009Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James C Stolzenbach Research Topics

Disease

14Dyslipidemias (Dyslipidemia)
06/2014 - 12/2008
3Coronary Disease (Coronary Heart Disease)
06/2014 - 01/2008
2Hypertriglyceridemia
02/2011 - 01/2010
2Type 2 Diabetes Mellitus (MODY)
02/2011 - 01/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2014
1Chronic Renal Insufficiency
08/2013
1Myotoxicity
01/2010
1Hypercholesterolemia
01/2010
1Rhabdomyolysis
01/2010
1Nasopharyngitis
12/2008
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2008
1Headache (Headaches)
12/2008
1Back Pain (Backache)
12/2008
1Hemorrhage
07/2003
1Sepsis (Septicemia)
07/2003

Drug/Important Bio-Agent (IBA)

15fenofibric acidFDA Link
06/2014 - 12/2008
13LipidsIBA
08/2013 - 01/2008
8LDL CholesterolIBA
06/2014 - 01/2009
8Rosuvastatin Calcium (Crestor)FDA Link
08/2013 - 01/2009
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2014 - 12/2008
7Triglycerides (Triacylglycerol)IBA
06/2014 - 01/2009
6HDL CholesterolIBA
06/2014 - 01/2009
6oxidized low density lipoproteinIBA
02/2011 - 01/2009
4Atorvastatin (Lipitor)FDA Link
06/2014 - 02/2009
42- (4- (4- chlorobenzoyl)phenoxy)- 2- methylpropanoic acidIBA
05/2009 - 01/2009
3Simvastatin (Zocor)FDA LinkGeneric
02/2011 - 01/2009
2Fibric Acids (Fibrates)IBA
06/2014 - 01/2010
2Choline (Choline Chloride)IBA
06/2014 - 01/2009
2ApolipoproteinsIBA
02/2011 - 01/2010
1Fenofibrate (CiL)FDA LinkGeneric
06/2014
1Apolipoproteins B (ApoB)IBA
02/2011
1Ezetimibe (Zetia)FDA Link
10/2010
1LDL Lipoproteins (beta Lipoproteins)IBA
02/2009
1HDL LipoproteinsIBA
02/2009
1SaltsIBA
01/2009
1Arginine (L-Arginine)FDA Link
07/2003
1Citric Acid (Citrate)FDA LinkGeneric
07/2003
1BuffersIBA
07/2003
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
07/2003
1TifacoginIBA
07/2003
1Thromboplastin (Tissue Factor)IBA
07/2003

Therapy/Procedure

13Therapeutics
06/2014 - 12/2008
1Aftercare (After-Treatment)
02/2011
1Intravenous Infusions
07/2003